News
Popular searches: Influenza, Childhood cancer, Endometriosis, Inflammation
-
A scientific silver lining
Researchers were aiming to find a genetic solution to a rare and devastating disease but were not able to identify one. However, in the process they identified a crucial factor in one of life’s most essential processes.… Read more
-
Hudson Institute CEO joins international science advisory council
Australia’s role in international science leadership has been reconfirmed with the appointment of Hudson Institute Hudson Institute Director and CEO, Professor Elizabeth Hartland AM FAHMS, to the Human Frontier Science Program’s Council of Scientists.… Read more
-
Happy Mother’s Day as Hudson team gets ovarian cancer research grant
A Hudson Institute research project aimed at reducing the recurrence of ovarian cancer has been awarded a significant grant by the Ovarian Cancer Research Foundation (OCRF).… Read more
-
Kinder, gentler diagnosis of Primary Aldosteronism (PA)
Not content with drawing attention to the condition and improving its treatment, the people behind Hudson Institute’s Primary Aldosteronism Centre of Excellence (PACE) have now identified a faster, gentler way of identifying its cause.… Read more
-
Hudson flu specialist in the NHMRC spotlight
As Australia approaches another flu season, the nation’s peak medical research funding body has recognised a Hudson Institute researcher for her pioneering work on influenza.… Read more
-
Cytokine structure shown to be key to controlling numerous diseases
In a comprehensive review published in Nature Reviews Immunology, one of the most respected scientific journals, our team synthesised emerging insights into how cytokines are regulated through their structural assembly. Cytokines are small signalling proteins released by immune cells that act as messengers, allowing cells to communicate. They coordinate immune responses, tissue repair and many other… Read more
-
One-two punch: flu treatment protects lungs & minimises pneumonia
A new flu treatment could drastically reduce one of flu’s deadliest complications – bacterial pneumonia – by helping the lungs defend themselves, rather than targeting the virus directly.… Read more
-
Fulbright Scholarship to support UCB therapy trial for preterm babies
Neonatologist and clinician-scientist Associate Professor Atul Malhotra from The Ritchie Centre, the School of Clinical Sciences at Monash Health, and Monash Children’s Hospital, has been awarded a Fulbright Professional Coral Sea Scholarship to support the US implementation of an umbilical cord blood (UCB) cell therapies clinical trial for extremely preterm babies. … Read more
-
Mysteries of the microbiome’s potential link to autism
As understanding of the gut microbiome continues to grow, attention is turning to its potential impact on brain development, with major research investment being devoted to better assess the role of the maternal and developing infant gut microbiomes in healthy infant neurodevelopment.… Read more
-
Intern sees cancer research from both sides
A young woman with a rare perspective on pediatric cancer is now considering where science can take her after completing a successful internship at Hudson Institute.… Read more